CT Chest Findings in Acute Exacerbation of RA-ILD
In acute exacerbation of rheumatoid arthritis-associated interstitial lung disease, chest CT shows new bilateral ground-glass opacities and/or consolidation superimposed on the pre-existing baseline ILD pattern (reticular abnormalities, traction bronchiectasis, or honeycombing). 1
Key Imaging Features
Primary Diagnostic Findings
The hallmark CT finding is new airspace disease developing on top of chronic fibrotic changes 2. Specifically, you will see:
- Bilateral ground-glass opacities - These represent the acute inflammatory component and are the most consistent finding 1
- Consolidation - Often present, particularly in dependent lung regions during the early exudative phase 1
- Superimposed on baseline pattern - The new acute changes overlay whatever chronic ILD pattern was present (UIP, NSIP, or other patterns) 1
Distribution Patterns
The acute changes typically show:
- Bilateral and often patchy distribution 1
- Can affect both upper and lower lobes, though lower lobe predominance is common given baseline RA-ILD distribution 3
- The extent and distribution of CT findings have prognostic value - more extensive involvement correlates with worse outcomes 2
Underlying Chronic Features
The baseline RA-ILD pattern visible beneath the acute changes may include:
- Reticular abnormalities
- Traction bronchiectasis
- Honeycombing (if UIP pattern)
- Architectural distortion 1
Critical Diagnostic Role of CT
CT chest without IV contrast is the imaging modality of choice for confirming acute exacerbation 2. The ACR Appropriateness Criteria (2021) explicitly state that development of new airspace disease on CT is a required diagnostic feature for acute exacerbation of diffuse lung disease 2.
Why CT is Essential
- Confirms the diagnosis - Demonstrates the characteristic new airspace abnormalities 2
- Excludes alternative diagnoses - Rules out pneumothorax, infection, malignancy, or heart failure that could mimic exacerbation 2
- Provides prognostic information - Quantitative assessment of lung volume loss and extent of involvement predicts mortality risk 3
Quantitative Assessment
Recent evidence shows that standardized 3D-CT lung volume measurements can accurately assess disease severity and mortality risk in AE-RA-ILD 3. Patients show:
- Substantial volume loss in both upper and lower lobes at acute exacerbation compared to baseline
- Decreased standardized 3D-CT lung volume independently predicts worse prognosis
- A composite model of age and standardized 3D-CT lung volume successfully stratifies mortality risk 3
Important Caveats
Contrast is not needed for diagnosing acute exacerbation - non-contrast CT is sufficient and preferred 2. IV contrast may only be helpful if you're specifically evaluating for alternative diagnoses like pulmonary embolism.
Chest radiography is inadequate - Multiple studies demonstrate CT's superior sensitivity and specificity over plain films for evaluating diffuse lung disease 2. Radiographs serve primarily to exclude gross alternative diagnoses like pneumothorax but cannot reliably diagnose or characterize acute exacerbation.
Acute exacerbation can occur with any baseline CT pattern - While most literature focuses on UIP pattern, acute exacerbation has been documented in RA-ILD patients with non-UIP patterns on CT 4. Don't assume absence of UIP pattern means no risk of acute exacerbation.
Pathologic Correlation
When biopsy is performed (though rarely needed if CT is characteristic), histology typically shows: